Tag: Vaso-Occlusive Crisis

Pfizer to acquire Oxbryta developer Global Blood Therapeutics for $5.4bn

pallavi123- August 8, 2022

Pfizer has agreed to acquire Global Blood Therapeutics (GBT), a publicly-listed American biopharma company, in a deal worth around $5.4 billion with an aim to ... Read More

Novartis bags Adakveo FDA approval to reduce VOCs in sickle cell disease

pharmanewsdaily- November 16, 2019

Adakveo FDA approval : Swiss drugmaker Novartis has bagged approval for Adakveo (crizanlizumab-tmca) from the US Food and Drug Administration (FDA) for its use in ... Read More